The r6le of the beta-hemolytic Streptococcus in the etiology of rheumatic fever has attracted considerable attention for the last twenty or more years. Although epidemiological studies, particularly those indicating a high incidence of streptococcic pharyngitis preceding first attacks or recurrences of rheumatic disease., have furnished highly suggestive evidence of the importance of this organism in the pathogenesis of this disorder, the exact mechanisms involved have not yet been elucidated. The development of a hypersensitivity reaction to Streptococcus pyogenes or to some of its endo-or extracellular products has been suggested by many investigators mainly on the basis of two observations: (i) the presence of a "latent period" between the initial streptococcal infection and the subsequent development of rheumatic fever, and (ii) the appearance of various antibodies to the Streptococcus and its products with greater frequency, in higher concentration, and persisting for a longer time in the rheumatic state than in uncomplicated streptococcosis.
The r6le of the beta-hemolytic Streptococcus in the etiology of rheumatic fever has attracted considerable attention for the last twenty or more years. Although epidemiological studies, particularly those indicating a high incidence of streptococcic pharyngitis preceding first attacks or recurrences of rheumatic disease., have furnished highly suggestive evidence of the importance of this organism in the pathogenesis of this disorder, the exact mechanisms involved have not yet been elucidated. The development of a hypersensitivity reaction to Streptococcus pyogenes or to some of its endo-or extracellular products has been suggested by many investigators mainly on the basis of two observations: (i) the presence of a "latent period" between the initial streptococcal infection and the subsequent development of rheumatic fever, and (ii) the appearance of various antibodies to the Streptococcus and its products with greater frequency, in higher concentration, and persisting for a longer time in the rheumatic state than in uncomplicated streptococcosis.
A large number of studies of specific and non-specific serologic reactions have been carried out in an attempt to characterize the immunological reactive pattern of the rheumatic and to contrast it with uncomplicated streptococcal infection in order to detect differences that might be of help in unmasking the mechanisms involved or in establishing the early diagnosis of the rheumatic state. Investigations of the serum content of anti-streptolysin, anti-streptokinase, anti-M, anti-C, anti-hyaluronidase, anti-X, antitrypsin, C-reactive protein, beta-hemolytic streptococcal agglutinin and bactericidal antibody, among others, have been thought to indicate that some of these appear more frequently, are present in larger quantities, and persist longer in patients with rheumatic fever than in those who have uncomplicated streptococcosis. None of these studies, however, have succeeded in attaching an unquestionable direct causal relationship of any of these immune substances to the pathogenesis of rheumatic fever. Careful evaluation of the voluminous literature on this subject, which cannot be reviewed in this paper because of limitations of space, permits only one conclusion-positive reactions with the various antibodies mentioned above indicate no more than recent experience with the beta-hemolytic Streptococcus. Although it has been suggested that their presence in larger numbers of patients, their higher titers, and longer persistence can be explained on a greater degree of immunological reactivity of the rheumatic subject, this still remains to be proved.
The purpose of this paper is to report the results of a search for antibody to one of the endocellular materials of the Streptococcus, the group specific carbohydrate or C substance, in the serums of patients with scarlet fever, rheumatic fever, and a number of unrelated infections in order to determine its possible importance in the pathogenesis of rheumatic fever, and to evaluate its significance in the diagnosis of this disease.
Most of the investigations of the incidence and significance of antibody to specific streptococcal polysaccharide have been carried out in cases of rheumatoid and other types of arthritis. Using crude preparations of this carbohydrate, Dawson and his co-workers' reported a much higher incidence of positive reactions with the serums of rheumatoid arthritics than with those of individuals who had scarlet fever, glomerular nephritis, osteoarthritis, hypertension, diabetes mellitus, bacteremia due to a non-hemolytic Streptococcus, and "non-articular rheumatism." Bruce and Caswell' employed crude hydrochloric acid extracts of the beta-hemolytic Streptococcus and found that 68.7 per cent of a group who suffered from rheumatoid arthritis had anti-C antibody in their blood, while 13 patients with osteomyelitis and 10 normal people did not Reports of the presence of precipitin for specific streptococcal carbohydrate in rheumatic fever and acute streptococcal pharyngitis are few and controversial. This antibody could not be detected by Coburn and Pauli' in a large number of individuals with rheumatic fever. Seegal and his coworkers11 found the highest incidence of positive anti-C reactions in cases of rheumatoid arthritis but demonstrated them also in about 45 per cent of patients with acute hemolytic streptococcal infections, in one-third of those with endocarditis due to Strep. viridans, and in 12 per cent of acute glomerular nephritides. Studies of normal controls and of people with noninfectious diseases revealed this precipitin in from zero to 10 per cent. In a small group of cases of rheumatic fever, Chassis and McEwen' detected positive reactions with group A polysaccharide in 100 per cent; in 8 patients with scarlet fever only 25 per cent exhibited this antibody. The most recent study of this subject is that of Rantz and Randall'0 who reported that about 8 per cent of people suffering Group A hemolytic streptococcal infections developed precipitating antibody for the specific polysaccharide during the course of their illness. The immune response was usually maximal by the end of the fourth week; no relationship could be established between it and "the nature of the initial illness" or the development of suppurative complications. In patients in whom arthritis appeared late in the course of the disease anti-C precipitins were demonstrable frequently, either initially or during convalescence, but in those with late fever, they never appeared. When carditis supervened late in the course of the disease, about 6 per cent of those who had no detectable antibody at the start of their illness developed it during recovery.
The studies reported in this paper indicate that precipitating antibody for the group-specific carbohydrate of Group A Streptococcus pyogenes is detectable with no greater frequency in patients with rheumatic fever than in those who have uncomplicated streptococcal pharyngitis. As a matter of fact, this precipitin is present so often in many unrelated infections that it appears to have little or no significance even in detecting recent infection with the beta-hemolytic Streptococcus.
MATERIALS AND METHODS
Five hundred and thirty-seven patients admitted to the Haynes Memorial Hospital for the treatment of a large variety of infectious diseases were the subjects of this study. Cultures of the nose and throat were made in every case on the day of admission and on the following day. All of the streptococci isolated were subjected to grouping and typing. Ten milliliters of blood were withdrawn aseptically from each person at the time of admission and again on the fourteenth day, wherever possible. In those with known streptococcal infections, blood was obtained on the day of entry to the hospital, 14 days later, and at the time of discharge. After clotting, the serum was removed and stored in the deep freeze refrigerator until tested.
The group specific polysaccharide was prepared in the following manner. A strain of Streptococcus pyogenes, Group A Type 3, which had been frequently passed into mice in order to maintain a high degree of virulence, was the source of the carbohydrate used in this study. The bacteria from 30 liters of heart-infusion-yeast-tryptose broth were obtained by centrifugation after 18 hours of incubation at 370 C. They were suspended in 200 ml. of N/20 HCl and heated for 10 minutes in a boiling water bath. Extraction in hydrochloric acid was repeated six times and the extracts pooled. After clearing by centrifugation, the combined extracts were neutralized with Ni NaOH.
The precipitate which formed was discarded and to the supernatant were added 20 gms. of sodium acetate per liter and 3-4 volumes of 95 per cent ethyl alcohol. Most of the type-specific nucleoprotein (M substance) has been shown to be precipitated by this procedure and the polysaccharide to be left in solution, according to Lancefield.6 The supernatant fluid was concentrated to a small volume in vacuo at a temperature not exceeding 37°C. and the salts dissolved in distilled water. Three volumes of alcohol were added, the solution placed at ice box temperature overnight and the precipitate then removed by centrifugation. The supernatant was again concentrated to a small volume in vacuo at a temperature not above 37°C. This material was dialyzed through a parchment bag because Lancefield had found that the group specific polysaccharide was dialyzable through parchment but not through special collodion membranes. Advantage of this phenomenon was taken in order to shorten the process of purification previously described by Lancefield.7 Dialysis was set up in a closed system against distilled water and allowed to proceed for twenty-four hours in the ice box. The dialysate was removed and the procedure repeated five times. All of the dialysates were then pooled and three volumes of ethyl alcohol added. A very small quantity of precipitate resulted. After centrifugation, the supernatant was again concentrated in vacuo to dryness. The material was dissolved in 0.85 per cent NaCl solution. Examination for the presence of Type 3 M substance and Group A polysaccharide, using potent specific antisera, revealed complete absence of the type specific nucleoprotein and large quantities of carbohydrate A. This solution, diluted to the point where it gave 4 plus reactions with potent anti-Group A serum after 2 hours of incubation at 370 C. and 24 hours' storage in the ice box, was the one used in performing all of the precipitin tests reported in this paper. All of the tests were set up in duplicate and all, whether positive or negative, were repeated twice.
The following'method was used to detect the presence of precipitating antibody for the purified Group A carbohydrate. The C-containing solution was layered over the patient's serum in a capillary precipitin tube and incubated at 370 C. for two hours. After 24 hours' storage in the ice box all the tubes were examined for precipitation and again placed at low temperature. Readings were made again after 48 and 72 hours of ice box storage. For every test, a control consisting of the bacterial extract plus saline and of the patient's serum plus saline was set up. The results were not recorded in terms of degree of precipitation but only as positive or negative.
RESULTS

Streptococcal Infections
One hundred twenty patients with scarlet fever were studied. The serum of 40 (33.3 per cent) showed precipitation when mixed with the purified group-specific polysaccharide. Seventy-five per cent of these had Cprecipitin at the time of admission to the hospital but in the remainder, this antibody was absent in the initially drawn serum but was present 14 days later. There appeared to be no correlation between age of the patients, the severity of the disease, the persistence of streptococci in the pharynx, and the development of suppurative or non-suppurative complications, and the appearance of anti-polysaccharide precipitins.
Seven cases of erysipelas were examined; none of them developed antibody for the C substance. Of 24 individuals with suppurative otitis media due to Streptococcus pyogenes, 12 (50 per cent) exhibited the presence of carbohydrate precipitin two weeks after admission to the hospital. In none of them was there any relation between severity and complications of the primary disease and the development of this immune reaction.
Seventy-six patients with acute rheumatic fever were studied. All of them had obvious clinical rheumatic disease; those with questionable syndromes were excluded from the investigation. The precipitin reaction was positive in only 18 (23.7 per cent). In every instance in which this antibody was detected it was present at the time of admission to the hospital. None of those which were initially negative subsequently became positive. There was no relation between the presence or degree of severity of carditis or arthritis or the duration of rheumatic activity and the development of polysaccharide precipitin.
Only six cases of acute glomerulonephritis were available for study. Of these, three (50 per cent) gave a positive reaction for streptococcal group specific polysaccharide at the time of admission to the hospital; in the others, this antibody was not detectable even late in the course of the disease.
The results obtained indicate that the development of precipitating antibody for purified group A specific polysaccharide of the beta-hemolytic Streptococcus does not take place in every patient infected by this organism. There also does not seem to be any relation between severity of the primary streptococcal disease or of its complications and the frequency with which this type of immune reaction appears. It is quite striking that in erysipelas this precipitin was never detected; this observation must be qualified, however, by the fact that only a few patients with this disease were studied. Most interesting is the demonstration of a somewhat lower incidence of positive reactions in patients with frank rheumatic fever than in those who had streptococcic pharyngitis without developing this complication. Although the frequency of positive reactions in acute glomerulonephritis was somewhat higher than in scarlet or rheumatic fever, this may be accounted for by the relatively small number of cases examined.
These data suggest that the development of antibody to the group-specific carbohydrate of the Streptococcus is without significance either in the diagnosis of Streptococcosis (this point is further emphasized by the results presented below) or in the pathogenesis of rheumatic fever or glomerulonephritis. Absence of this precipitin does not rule out the presence of streptococcic infection, since at least two-thirds of the patients with scarlet fever never developed it even during the course of persistent streptococcic infection despite the fact that some of them exhibited suppurative complications due to Strep. pyogenes.
Infections Other Than Those Due to the Streptococcus In order to evaluate the importance of the presence of precipitin for group A polysaccharide in the blood of patients with infections due to Streptococcus pyogenes, the serum of 304 individuals with illnesses due to (2) . Virus infectionsmeasles (28), varicella (20), mumps (7), infectious mononucleosis (6), rubella (3), viral diarrhea of infants (2) , probable viral pharyngitis (19), viral tracheitis (1), and infectious hepatitis (1) . Miscellaneous infections and other diseases-scabies (61), secondary and tertiary syphilis (42), monilial stomatitis (2), cervical adenopathy of unknown etiology (2), dermatitis (3), appendicitis (1) , and scurvy (1).
Precipitin for group A specific carbohydrate of the beta-hemolytic Streptococcus was demonstrable only in the following diseases: diphtheria, varicella, rubella, scabies, syphilis, and in the asymptomatic diphtheria carrier state. The antibody was present most frequently in diphtheria carriers-100 per cent; the significance of this is difficult to evaluate, however, since only three cases were investigated. In 61 individuals with scabies, 25 or 41 per cent gave positive reactions. Fifteen per cent of the instances of varicella, 33.3 per cent of those with rubella, 14.9 per cent of the syphilitics, and 12.5 per cent of the patients with active diphtheritic pharyngitis yielded precipitins for the C substance. The remaining 133 persons suffered from 25 different disease processes, mostly various infections. Specific streptococcal carbohydrate precipitin was not detected in any members of this group. The results of the entire study are presented in Table 1 .
DISCUSSION
Many of the investigations that have been carried out in an attempt to demonstrate precipitating antibodies for the group specific polysaccharide of Group A beta-hemolytic Streptococcus have been somewhat confused by the use of crude preparations which contained not only the carbohydrate, but also type specific nucleoprotein M and the non-specific nucleoprotein P. The data presented in this paper were obtained with highly purified streptococcal polysaccharide. Advantage was taken of Lancefield's observation7 that the group specific substance is dialyzable through ordinary parchment membranes. The method of purifying the material which was used in the present study was thus made more simple while the degree of purity was increased at the same time. As was pointed out above, the preparation employed was entirely free of the type-specific nucleoprotein as shown by its failure to be precipitated by potent Type 3 specific antiserum.
The results obtained in various types of streptococcal disease are somewhat at variance with other published reports. Unlike the studies of Coburn and Pauli8 who could not demonstrate precipitin for streptococcal carbohydrate in the serums of patients with pharyngitis or rheumatic fever, or those of Chassis and McEwen' who found this antibody in 100 per cent of rheumatics, the present investigation revealed that about one-third of cases of scarlet fever and about one-fourth of those with rheumatic fever had positive reactions. The data of Rantz and Randall'0 suggest a lower incidence of anti-C antibody-8 per cent in Group A hemolytic streptococcal infections. The failure to detect the C-precipitin in seven cases of erysipelas cannot be explained. The observations demonstrating a lack of relationship between the severity of the initial disease or the appearance of suppurative complications and the development of the immune reaction are in accord with those of Rantz and Randall.'0 Most striking is the fact that not all of the patients with proved streptococcal infections exhibited precipitating antibody for the group-specific carbohydrate. This may be due to the relatively poor antigenicity of the polysaccharide even in its natural state in the organism. It is well known that injection of whole streptococci into experimental animals leads to the development of active C-precipitins. The rate of response may be slow, however, and many repeated injections of large numbers of streptococci may be necessary before detectable antibody can be demonstrated. It is of considerable significance that cases of scarlet fever appeared to produce carbohydrates precipitin with somewhat greater frequency than those who had rheumatic fever. This tends to minimize consideration of the role of sensitization to group-specific streptococcal polysaccharide as a possible mechanism in the development of the rheumatic state. Since this antibody appeared in only about one-third of the cases of bacteriologically proved streptococcal pharyngitis, failure to detect its presence obviously does not eliminate the possibility that an individual has had recent experience with the Streptococcus.
The demonstration of a relatively high incidence of carbohydrateprecipitating antibody in a number of infectious diseases produced by agents completely unrelated, so far as is known, to the beta-hemolytic Streptococcus is interesting and important. The frequent occurrence (41 per cent) of this precipitin in scabies and its demonstration in 15 per cent of individuals with syphilis or chicken pox raises some interesting problems. It is entirely possible that the patients with these diseases who exhibited this antibody had also had a recent streptococcal infection, although no evidence of this was present at the time they were studied. If the anti-C precipitin persists in the blood for a long time, its presence in individuals with scabies, for example, might be explained on the ground of streptococcic invasion months or years prior to the present examination. The possibility that Sarcoptes scabei may possess a polysaccharide similar or closely related to that of Strep. pyogenes also merits some consideration, although there is no evidence in support of such a speculation. The demonstration of carbohydrate precipitating antibody in the blood of patients, without clinical or laboratory evidence of recent experience with the beta-hemolytic Streptococcus, cannot be used to prove or disprove the diagnosis of acute streptococcosis or rheumatic fever. CONCLUSIONS 1. A modified method for the purification of the group-specific polysaccharide of Group A Streptococcus is described.
2. The incidence of precipitin for streptococcal carbohydrate is somewhat lower in rheumatic fever than in uncomplicated streptococcal pharyngitis.
3. Only about one-third of patients with bacteriologically proved scarlet fever develop anti-polysaccharide antibody. 4 . Precipitating antibody for streptococcal carbohydrate is frequently demonstrable in the absence of streptococcic infection.
5. Absence of anti-C antibody does not rule out the presence of active streptococcic disease or rheumatic fever.
6. Hypersensitization to group-specific polysaccharide is of no significance in the pathogenesis of the rheumatic state.
